BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3037505)

  • 21. Quantitative analysis of HLA DR expression and lymphocytic infiltrate in laryngeal cancer including clinical and morphological correlations.
    Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
    Gen Diagn Pathol; 1998 Apr; 143(5-6):297-303. PubMed ID: 9653911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance.
    Bonagura VR; Hatam L; DeVoti J; Zeng F; Steinberg BM
    Clin Immunol; 1999 Dec; 93(3):302-11. PubMed ID: 10600342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the the cyclin-kinase inhibitors p21(WAF1) and p27(Kip1) and the p53 tumor suppressor genes in adult-onset laryngeal papillomas.
    Erdamar B; Keles N; Kaur A; Suoglu Y; Kiyak E
    Eur Arch Otorhinolaryngol; 2002 Nov; 259(10):516-20. PubMed ID: 12434183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Classification of laryngeal papillomas and papillomatosis (author's transl)].
    Neumann OG; Klopp L; Franz B
    Laryngol Rhinol Otol (Stuttg); 1980 Jan; 59(1):57-65. PubMed ID: 7392741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells in precancerous lesions of the larynx.
    Sprinzl GM; Hussl B; Obrist P; Yoneda K; Thumfart WF; Romani N; Schrott-Fischer A
    Laryngoscope; 2000 Jan; 110(1):13-8. PubMed ID: 10646708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of laryngeal papillomas with a combined therapy: antiviral and immunostimulating].
    Sarău M; Topciu V; Marin I; Mihăilescu R
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):82-6. PubMed ID: 8173218
    [No Abstract]   [Full Text] [Related]  

  • 29. Laryngeal papillomas: classification and course.
    Lindeberg H; Oster S; Oxlund I; Elbrønd O
    Clin Otolaryngol Allied Sci; 1986 Dec; 11(6):423-9. PubMed ID: 3815867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
    Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
    Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of T6+ and HLA/DR+ Langerhans cells in normal and inflamed human gingiva.
    Hitzig C; Monteil RA; Charbit Y; Teboul M
    J Biol Buccale; 1989 Jun; 17(2):103-8. PubMed ID: 2788648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of papillomavirus antigen in paraffin sections of laryngeal papillomas.
    Braun L; Kashima H; Eggleston J; Shah K
    Laryngoscope; 1982 Jun; 92(6 Pt 1):640-3. PubMed ID: 6177992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Juvenile papillomatosis of the larynx].
    Krajina Z; Lenarcić-Cepelja I; Jusić D; Mazuran R; Vranesić D; Stavjenić A
    Lijec Vjesn; 1989 Nov; 111(11):419-23. PubMed ID: 2636300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autogenous vaccine treatment of juvenile laryngeal papillomatosis.
    Stephens CB; Arnold GE; Butchko GM; Hardy CL
    Laryngoscope; 1979 Oct; 89(10 Pt 1):1689-96. PubMed ID: 228137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
    Löning T
    Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and molecular biology studies of laryngeal papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
    Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
    Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
    Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD40 and CD40 ligand in the human conjunctival epithelium.
    Bourcier T; De Saint-Jean M; Brignole F; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):120-6. PubMed ID: 10634610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracheal involvement in laryngeal papillomatosis.
    Weiss MD; Kashima HK
    Laryngoscope; 1983 Jan; 93(1):45-8. PubMed ID: 6296564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.